Identification	O
of	O
nucleotide	B-DNA
sequences	I-DNA
that	O
regulate	O
transcription	O
of	O
the	O
MCF13	O
murine	O
leukemia	O
virus	O
long	B-DNA
terminal	I-DNA
repeat	I-DNA
in	O
activated	O
T	B-cell_type
cells	I-cell_type
.	O

The	O
region	O
downstream	O
of	O
the	O
enhancer	B-DNA
(	O
DEN	B-DNA
)	O
of	O
the	O
long	B-DNA
terminal	I-DNA
repeat	I-DNA
of	O
the	O
mink	O
cell	O
focus-forming	O
murine	O
leukemia	O
virus	O
is	O
important	O
for	O
viral	O
pathogenicity	O
.	O

Another	O
important	O
activity	O
of	O
DEN	B-DNA
is	O
its	O
control	O
of	O
transcription	O
in	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
,	O
and	O
we	O
have	O
determined	O
that	O
an	O
NF-kappaB	B-protein
site	O
is	O
critical	O
for	O
this	O
activity	O
.	O

JOURNAL	NULL
OF	NULL
ViroLOGYy	NULL
,	NULL
Mar	NULL
.	NULL

1997	NULL
,	NULL
p.	NULL
2572-2576	NULL
0022-538X	NULL
,	NULL
/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

71	NULL
,	NULL
No	NULL
.	NULL

3	NULL
Identification	NULL
of	NULL
Nucleotide	NULL
Sequences	NULL
That	NULL
Regulate	NULL
Transcription	NULL
of	NULL
the	NULL
MCF13	NULL
Murine	NULL
Leukemia	NULL
Virus	NULL
Long	NULL
Terminal	NULL
Repeat	NULL
in	NULL
Activated	NULL
T	NULL
Cells	NULL
FAYTH	NULL
K.	NULL
YOSHIMURA	NULL
,	NULL
*	NULL
MILENA	NULL
CANKOVIC	NULL
,	NULL
RONALD	NULL
SMELTZ	NULL
,	NULL
AND	NULL
SITI	NULL
IBRAHIM	NULL
Department	NULL
of	NULL
Immunology	NULL
and	NULL
Microbiology	NULL
,	NULL
Wayne	NULL
State	NULL
University	NULL
,	NULL
Detroit	NULL
,	NULL
Michigan	NULL
48201	NULL
Received	NULL
1	NULL
August	NULL
1996/Accepted	NULL
27	NULL
November	NULL
1996	NULL
The	NULL
region	NULL
downstream	NULL
of	NULL
the	NULL
enhancer	NULL
(	NULL
DEN	NULL
)	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
the	NULL
mink	NULL
cell	NULL
focus-forming	NULL
murine	NULL
leukemia	NULL
virus	NULL
is	NULL
important	NULL
for	NULL
viral	NULL
pathogenicity	NULL
.	NULL

Another	NULL
important	NULL
activity	NULL
of	NULL
DEN	NULL
is	NULL
its	NULL
control	NULL
of	NULL
transcription	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
we	NULL
have	NULL
determined	NULL
that	NULL
an	NULL
NF-KB	NULL
site	NULL
is	NULL
critical	NULL
for	NULL
this	NULL
activity	NULL
.	NULL

Our	NULL
studies	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
region	NULL
that	NULL
lies	NULL
between	NULL
the	NULL
enhancer	NULL
and	NULL
promoter	NULL
(	NULL
DEN	NULL
,	NULL
for	NULL
downstream	NULL
of	NULL
enhancer	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
of	NULL
a	NULL
mink	NULL
cell	NULL
focus-forming	NULL
murine	NULL
leukemia	NULL
virus	NULL
(	NULL
MCF	NULL
MLV	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
this	NULL
region	NULL
is	NULL
important	NULL
for	NULL
the	NULL
pathogenicity	NULL
of	NULL
this	NULL
retrovirus	NULL
,	NULL
which	NULL
induces	NULL
thymic	NULL
lymphoma	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
DEN	NULL
region	NULL
attenuated	NULL
the	NULL
lymphomagenicity	NULL
of	NULL
the	NULL
MCF13	NULL
MLV	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Our	NULL
analysis	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
MCF13	NULL
DEN	NULL
sequences	NULL
revealed	NULL
that	NULL
it	NULL
is	NULL
the	NULL
only	NULL
region	NULL
of	NULL
the	NULL
LTR	NULL
that	NULL
controls	NULL
transcription	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
nucleotide	NULL
sequences	NULL
that	NULL
regulate	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
DEN	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
gel	NULL
shift	NULL
assays	NULL
to	NULL
detect	NULL
protein-DNA	NULL
complexes	NULL
that	NULL
are	NULL
unique	NULL
for	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
compared	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
protein	NULL
isolated	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
grown	NULL
under	NULL
different	NULL
conditions	NULL
to	NULL
a	NULL
°°P-labeled	NULL
DEN	NULL
DNA	NULL
fragment	NULL
that	NULL
corresponded	NULL
to	NULL
the	NULL
region	NULL
between	NULL
the	NULL
RsaI	NULL
and	NULL
DraI	NULL
sites	NULL
of	NULL
the	NULL
MCF13	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

P-labeled	NULL
DEN	NULL
DNA	NULL
(	NULL
1	NULL
ng	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
4	NULL
g	NULL
of	NULL
nuclear	NULL
extract	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
in	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
N-2-hydroxyeth-ylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
)	NULL
-50	NULL
mM	NULL
NaCl-1	NULL
mM	NULL
EDTA-0.25	NULL
mM	NULL
EGTA-7	NULL
mM	NULL
B-mercaptoctha-nol-10	NULL
%	NULL
glycerol	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Samples	NULL
subsequently	NULL
were	NULL
electrophoresed	NULL
through	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.3X	NULL
TBE	NULL
buffer	NULL
(	NULL
1X	NULL
TBE	NULL
is	NULL
81	NULL
mM	NULL
Tris	NULL
base	NULL
,	NULL
81	NULL
mM	NULL
boric	NULL
acid	NULL
,	NULL
and	NULL
1.8	NULL
mM	NULL
EDTA	NULL
)	NULL
at	NULL
17	NULL
V/cm	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
X-Omat	NULL
film	NULL
with	NULL
a	NULL
DuPont	NULL
Lightning	NULL
Plus	NULL
intensifying	NULL
screen	NULL
at	NULL
-70°C	NULL
.	NULL

The	NULL
results	NULL
of	NULL
this	NULL
gel	NULL
shift	NULL
comparison	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
.	NULL

Nuclear	NULL
extracts	NULL
used	NULL
for	NULL
binding	NULL
were	NULL
isolated	NULL
from	NULL
Jurkat	NULL
cells	NULL
that	NULL
were	NULL
either	NULL
unactivated	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
activated	NULL
with	NULL
tetradecanoyl	NULL
phorbol	NULL
acetate	NULL
(	NULL
TPA	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
treated	NULL
only	NULL
with	NULL
ionomycin	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
TPA	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

We	NULL
detected	NULL
a	NULL
major	NULL
band	NULL
(	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
)	NULL
that	NULL
was	NULL
seen	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Competition	NULL
gel	NULL
shift	NULL
assays	NULL
revealed	NULL
that	NULL
this	NULL
major	NULL
band	NULL
represented	NULL
specific	NULL
protein	NULL
binding	NULL
to	NULL
DEN	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

For	NULL
these	NULL
assays	NULL
either	NULL
unlabeled	NULL
DEN	NULL
DNA	NULL
(	NULL
lanes	NULL
3	NULL
to	NULL
5	NULL
)	NULL
or	NULL
lambda	NULL
DNA	NULL
digested	NULL
with	NULL
BsfEI	NULL
restriction	NULL
endonuclease	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
8	NULL
)	NULL
was	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Immunology	NULL
and	NULL
Microbiology	NULL
,	NULL
Gordon	NULL
H.	NULL
Scott	NULL
Hall	NULL
,	NULL
Wayne	NULL
State	NULL
University	NULL
,	NULL
540	NULL
E.	NULL
Canfield	NULL
Ave.	NULL
,	NULL
Detroit	NULL
,	NULL
MI	NULL
48201	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
313	NULL
)	NULL
577-1571	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
313	NULL
)	NULL
577-1155	NULL
.	NULL

E-mail	NULL
:	NULL
fyoshi	NULL
@	NULL
med.wayne.edu	NULL
.	NULL

2572	NULL
preincubated	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
activated	NULL
Jurkat	NULL
cells	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
was	NULL
performed	NULL
to	NULL
identify	NULL
the	NULL
protected	NULL
bases	NULL
for	NULL
the	NULL
specific	NULL
protein-DNA	NULL
complex	NULL
detectable	NULL
only	NULL
with	NULL
activated	NULL
T-cell	NULL
nuclear	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

DEN	NULL
DNA	NULL
that	NULL
contained	NULL
either	NULL
°°P-labeled	NULL
coding	NULL
or	NULL
noncoding	NULL
strand	NULL
was	NULL
reacted	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
Jurkat	NULL
cells	NULL
treated	NULL
with	NULL
TPA	NULL
and	NULL
ionomycin	NULL
and	NULL
digested	NULL
with	NULL
DNase	NULL
I	NULL
before	NULL
elec-trophoresis	NULL
through	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

DNA	NULL
was	NULL
eluted	NULL
from	NULL
the	NULL
specific	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
and	NULL
after	NULL
phenol/chloroform	NULL
extraction	NULL
was	NULL
electrophoresed	NULL
through	NULL
an	NULL
8	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Footprints	NULL
of	NULL
the	NULL
bound	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
included	NULL
either	NULL
a	NULL
complete	NULL
consensus	NULL
sequence	NULL
for	NULL
the	NULL
NF-kB	NULL
transcription	NULL
factor	NULL
(	NULL
4	NULL
,	NULL
19	NULL
)	NULL
,	NULL
which	NULL
is	NULL
denoted	NULL
by	NULL
brackets	NULL
(	NULL
5'-GGGACTTITTCC-3	NULL
'	NULL
)	NULL
for	NULL
the	NULL
noncoding	NULL
strand	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
the	NULL
5'-half	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
5'-GGA	NULL
AA-3	NULL
``	NULL
)	NULL
for	NULL
the	NULL
coding	NULL
strand	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

For	NULL
the	NULL
noncoding	NULL
strand	NULL
we	NULL
also	NULL
detected	NULL
protection	NULL
of	NULL
six	NULL
bases	NULL
(	NULL
5'-GAAACT	NULL
-3	NULL
'	NULL
)	NULL
that	NULL
constitute	NULL
the	NULL
3	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
MLPal	NULL
protein	NULL
binding	NULL
site	NULL
that	NULL
we	NULL
determined	NULL
is	NULL
able	NULL
to	NULL
regulate	NULL
transcription	NULL
specifically	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
27	NULL
,	NULL
31	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Bases	NULL
that	NULL
were	NULL
protected	NULL
for	NULL
the	NULL
noncoding	NULL
and	NULL
coding	NULL
strands	NULL
are	NULL
indicated	NULL
by	NULL
a	NULL
bold	NULL
line	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
.	NULL

Because	NULL
we	NULL
observed	NULL
only	NULL
partial	NULL
protection	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
for	NULL
the	NULL
coding	NULL
strand	NULL
,	NULL
we	NULL
used	NULL
recombinant	NULL
NF-kB	NULL
p50	NULL
protein	NULL
(	NULL
Promega	NULL
Corp.	NULL
)	NULL
in	NULL
a	NULL
DNase	NULL
I	NULL
footprint	NULL
reaction	NULL
and	NULL
obtained	NULL
similar	NULL
results	NULL
(	NULL
compare	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
of	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
NF-kB	NULL
binding	NULL
under	NULL
our	NULL
conditions	NULL
resulted	NULL
in	NULL
only	NULL
partial	NULL
protection	NULL
of	NULL
the	NULL
coding	NULL
strand	NULL
.	NULL

The	NULL
functional	NULL
significance	NULL
of	NULL
the	NULL
NF-kB	NULL
and	NULL
the	NULL
3	NULL
'	NULL
half	NULL
of	NULL
the	NULL
MLPal	NULL
protein-binding	NULL
sites	NULL
for	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
DEN	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
was	NULL
examined	NULL
by	NULL
oligonucleotide-directed	NULL
mutagenesis	NULL
of	NULL
a	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
gene	NULL
construct	NULL
that	NULL
was	NULL
used	NULL
to	NULL
originally	NULL
identify	NULL
DEN	NULL
activity	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
NF-kB	NULL
and	NULL
MLPal	NULL
protein	NULL
binding	NULL
sites	NULL
in	NULL
DEN	NULL
,	NULL
there	NULL
are	NULL
sites	NULL
for	NULL
other	NULL
transcription	NULL
elements	NULL
,	NULL
such	NULL
as	NULL
ets	NULL
and	NULL
GATA	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
which	NULL
regulate	NULL
transcription	NULL
in	NULL
T	NULL
lymphocytes	NULL
(	NULL
15-17	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
ets	NULL
,	NULL
GATA	NULL
,	NULL
and	NULL
other	NULL
potential	NULL
binding	NULL
sites	NULL
may	NULL
not	NULL
have	NULL
been	NULL
detectable	NULL
by	NULL
our	NULL
gel	NULL
shift	NULL
and	NULL
DNase	NULL
I	NULL
footprinting	NULL
assays	NULL
because	NULL
of	NULL
possible	NULL
differences	NULL
in	NULL
the	NULL
abundancy	NULL
of	NULL
their	NULL
cognate	NULL
proteins	NULL
,	NULL
we	NULL
mutated	NULL
the	NULL
entire	NULL
DEN	NULL
region	NULL
to	NULL
identify	NULL
any	NULL
additional	NULL
elements	NULL
that	NULL
may	NULL
regulate	NULL
transcription	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Mutagenesis	NULL
was	NULL
performed	NULL
by	NULL
substituting	NULL
the	NULL
BamHI	NULL
restriction	NULL
endonuclease	NULL
recognition	NULL
sequence	NULL
for	NULL
each	NULL
identifiable	NULL
protein	NULL
binding	NULL
site	NULL
or	NULL
random	NULL
sequences	NULL
Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
NOTES	NULL
2573	NULL
ENHANCER	NULL
REPEATS	NULL
DEN	NULL
CAT	NULL
TATA	NULL
¥	NULL
TT	NULL
|	NULL
e	NULL
e	NULL
r—|——1	NULL
69	NULL
H	NULL
69	NULL
H	NULL
93	NULL
--	NULL
-I	NULL
+1	NULL
+35	NULL
+149	NULL
-	NULL
451	NULL
PstI	NULL
Rsa	NULL
I	NULL
Dra	NULL
I	NULL
Sma	NULL
I	NULL
[	NULL
I	NULL
I	NULL
|	NULL
U3	NULL
R	NULL
U5	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

MCF13	NULL
MLV	NULL
LTR	NULL
.	NULL

The	NULL
U3	NULL
,	NULL
R	NULL
,	NULL
and	NULL
US	NULL
regions	NULL
and	NULL
CAT	NULL
and	NULL
TATA	NULL
boxes	NULL
are	NULL
indicated	NULL
.	NULL

Numbering	NULL
is	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
site	NULL
of	NULL
transcription	NULL
,	NULL
which	NULL
is	NULL
shown	NULL
by	NULL
a	NULL
horizontal	NULL
arrow	NULL
.	NULL

Enhancer	NULL
repeats	NULL
are	NULL
depicted	NULL
as	NULL
two	NULL
69-bp	NULL
boxes	NULL
.	NULL

DEN	NULL
is	NULL
the	NULL
93-bp	NULL
region	NULL
between	NULL
the	NULL
enhancer	NULL
and	NULL
promoter	NULL
and	NULL
is	NULL
flanked	NULL
by	NULL
the	NULL
Rsal	NULL
and	NULL
Dral	NULL
sites	NULL
.	NULL

across	NULL
the	NULL
DEN	NULL
region	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Sayers	NULL
et	NULL
al	NULL
.	NULL

(	NULL
24	NULL
)	NULL
(	NULL
Amersham	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

All	NULL
mutations	NULL
were	NULL
verified	NULL
by	NULL
DNA	NULL
sequencing	NULL
(	NULL
Pharmacia	NULL
ALFexpress	NULL
instrument	NULL
;	NULL
Macromolec-ular	NULL
Core	NULL
Facility	NULL
at	NULL
the	NULL
Wayne	NULL
State	NULL
University	NULL
Medical	NULL
School	NULL
)	NULL
.	NULL

The	NULL
mutants	NULL
are	NULL
designated	NULL
in	NULL
Table	NULL
1	NULL
and	NULL
Fig	NULL
.	NULL

4	NULL
either	NULL
by	NULL
the	NULL
name	NULL
of	NULL
the	NULL
transcription	NULL
element	NULL
that	NULL
is	NULL
mutated	NULL
or	NULL
the	NULL
first	NULL
nucleotide	NULL
in	NULL
that	NULL
particular	NULL
mutated	NULL
sequence	NULL
.	NULL

The	NULL
numbering	NULL
of	NULL
the	NULL
nucleotides	NULL
is	NULL
based	NULL
on	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
MCF13	NULL
LTR	NULL
that	NULL
we	NULL
have	NULL
published	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
each	NULL
mutant	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
DEN	NULL
clone	NULL
(	NULL
wtDEN	NULL
)	NULL
in	NULL
Jurkat	NULL
cells	NULL
that	NULL
were	NULL
activated	NULL
by	NULL
treatment	NULL
with	NULL
TPA	NULL
and	NULL
ionomycin	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
CAT	NULL
activity	NULL
of	NULL
each	NULL
clone	NULL
is	NULL
expressed	NULL
as	NULL
a	NULL
percent	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
wild-type	NULL
DEN	NULL
clone	NULL
.	NULL

We	NULL
performed	NULL
transient	NULL
expression	NULL
assays	NULL
by	NULL
detecting	NULL
CAT	NULL
enzymatic	NULL
activity	NULL
in	NULL
total	NULL
cellular	NULL
protein	NULL
that	NULL
was	NULL
extracted	NULL
from	NULL
cells	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
with	NULL
Lipofectin	NULL
(	NULL
GIBCO/BRL	NULL
)	NULL
as	NULL
described	NULL
by	NULL
Chen	NULL
and	NULL
Yoshimura	NULL
(	NULL
11	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
mutations	NULL
of	NULL
the	NULL
NF-KB	NULL
site	NULL
had	NULL
the	NULL
greatest	NULL
effect	NULL
on	NULL
DEN	NULL
activity	NULL
,	NULL
with	NULL
reductions	NULL
to	NULL
14.1	NULL
and	NULL
11.2	NULL
%	NULL
of	NULL
wild-type	NULL
activity	NULL
for	NULL
m5'-NF-	NULL
«	NULL
B	NULL
-TPA	NULL
+TPA	NULL
-TPA	NULL
+TPA	NULL
-ION	NULL
+I0N	NULL
+I0N	NULL
ION	NULL
A	NULL
DEN	NULL
\	NULL
B	NULL
_	NULL
.	NULL

[	NULL
so	NULL
100	NULL
200|	NULL
[	NULL
so	NULL
100	NULL
200	NULL
-	NULL
to	NULL
ms.	NULL
and	NULL
m3'-NF-xB	NULL
,	NULL
respectively	NULL
.	NULL

Mutations	NULL
of	NULL
six	NULL
additional	NULL
sites	NULL
(	NULL
m279	NULL
,	NULL
m287	NULL
,	NULL
m3'MLPal	NULL
,	NULL
m323	NULL
,	NULL
m333	NULL
,	NULL
and	NULL
mets	NULL
)	NULL
each	NULL
had	NULL
a	NULL
moderate	NULL
effect	NULL
on	NULL
transcription	NULL
,	NULL
with	NULL
activities	NULL
ranging	NULL
from	NULL
38	NULL
to	NULL
57	NULL
%	NULL
of	NULL
that	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
.	NULL

The	NULL
m279	NULL
,	NULL
m287	NULL
,	NULL
and	NULL
m3'-MLPal	NULL
mutations	NULL
affect	NULL
sequences	NULL
in	NULL
the	NULL
MLP	NULL
protein	NULL
binding	NULL
site	NULL
,	NULL
which	NULL
we	NULL
have	NULL
observed	NULL
to	NULL
bind	NULL
multiple	NULL
proteins	NULL
(	NULL
30	NULL
)	NULL
and	NULL
which	NULL
is	NULL
juxtaposed	NULL
with	NULL
the	NULL
NF-kB	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
observed	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
NF-xB	NULL
often	NULL
requires	NULL
interactions	NULL
with	NULL
other	NULL
transacting	NULL
factors	NULL
(	NULL
18	NULL
,	NULL
23	NULL
,	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Because	NULL
our	NULL
DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
indicated	NULL
that	NULL
the	NULL
3	NULL
'	NULL
segment	NULL
of	NULL
the	NULL
MLPal	NULL
site	NULL
is	NULL
occupied	NULL
by	NULL
protein	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
for	NULL
NF-kB	NULL
to	NULL
interact	NULL
with	NULL
some	NULL
of	NULL
the	NULL
proteins	NULL
that	NULL
bind	NULL
MLPal	NULL
.	NULL

Although	NULL
Ets	NULL
binding	NULL
sites	NULL
that	NULL
regulate	NULL
transcription	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
promoter	NULL
and/or	NULL
enhancer	NULL
regions	NULL
of	NULL
the	NULL
LTR	NULL
of	NULL
T-cell	NULL
lym-phomagenic	NULL
MLVs	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
,	NULL
including	NULL
MCF13	NULL
,	NULL
this	NULL
is	NULL
the	NULL
first	NULL
observation	NULL
of	NULL
a	NULL
functional	NULL
ets	NULL
site	NULL
in	NULL
the	NULL
DEN	NULL
region	NULL
.	NULL

Because	NULL
the	NULL
BamHI	NULL
recognition	NULL
sequence	NULL
contains	NULL
a	NULL
potential	NULL
Ets	NULL
binding	NULL
site	NULL
(	NULL
13	NULL
)	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
this	NULL
element	NULL
on	NULL
transcription	NULL
may	NULL
be	NULL
greater	NULL
than	NULL
what	NULL
we	NULL
have	NULL
observed	NULL
.	NULL

The	NULL
bases	NULL
that	NULL
are	NULL
mu	NULL
A	NULL
DNA	NULL
NF-KB	NULL
25	NULL
50	NULL
100	NULL
200	NULL
mMLPal	NULL
25	NULL
50	NULL
100	NULL
200	NULL
C	NULL
C	NULL
*	NULL
TI	NULL
Sue	NULL
G	NULL
AJ	NULL
“	NULL
w	NULL
.	NULL

%	NULL
2	NULL
3	NULL
1	NULL
4	NULL
5	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Unique	NULL
protein-DNA	NULL
complex	NULL
for	NULL
DEN	NULL
detectable	NULL
with	NULL
activated	NULL
T-cell	NULL
extract	NULL
.	NULL

Shown	NULL
are	NULL
results	NULL
from	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
of	NULL
``	NULL
P-labeled	NULL
DEN	NULL
DNA	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
Jurkat	NULL
cells	NULL
(	NULL
lanes	NULL
:	NULL
2	NULL
,	NULL
unactivated	NULL
;	NULL
3	NULL
,	NULL
treated	NULL
with	NULL
TPA	NULL
and	NULL
ionomycin	NULL
;	NULL
4	NULL
,	NULL
treated	NULL
with	NULL
ionomycin	NULL
;	NULL
5	NULL
,	NULL
treated	NULL
with	NULL
TPA	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
represents	NULL
labeled	NULL
DEN	NULL
DNA	NULL
with	NULL
no	NULL
protein	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
unique	NULL
major	NULL
band	NULL
detectable	NULL
for	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Specificity	NULL
of	NULL
DNA	NULL
binding	NULL
by	NULL
nuclear	NULL
extract	NULL
from	NULL
activated	NULL
Jurkat	NULL
cells	NULL
.	NULL

Excess	NULL
amounts	NULL
of	NULL
unlabeled	NULL
DEN	NULL
or	NULL
lambda	NULL
DNA	NULL
as	NULL
indicated	NULL
above	NULL
lanes	NULL
3	NULL
to	NULL
8	NULL
were	NULL
added	NULL
to	NULL
nuclear	NULL
extract	NULL
from	NULL
activated	NULL
Jurkat	NULL
cells	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
labeled	NULL
probe	NULL
.	NULL

Lane	NULL
-	NULL
,	NULL
DEN	NULL
probe	NULL
with	NULL
no	NULL
protein	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
;	NULL
lane	NULL
+	NULL
,	NULL
reaction	NULL
without	NULL
competitor	NULL
DNA	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Competition	NULL
assay	NULL
for	NULL
NF-xB	NULL
binding	NULL
.	NULL

Protein	NULL
binding	NULL
was	NULL
detected	NULL
with	NULL
a	NULL
*°P-labeled	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
.	NULL

Nuclear	NULL
extract	NULL
for	NULL
these	NULL
reactions	NULL
was	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
treated	NULL
with	NULL
TPA	NULL
and	NULL
ionomycin	NULL
.	NULL

Excess	NULL
molar	NULL
amounts	NULL
of	NULL
unlabeled	NULL
DNA	NULL
are	NULL
indicated	NULL
above	NULL
lanes	NULL
3	NULL
to	NULL
10	NULL
.	NULL

Probe	NULL
alone	NULL
is	NULL
shown	NULL
in	NULL
lane	NULL
1	NULL
,	NULL
and	NULL
a	NULL
binding	NULL
reaction	NULL
without	NULL
competitor	NULL
DNA	NULL
is	NULL
shown	NULL
in	NULL
lane	NULL
2	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
major	NULL
band	NULL
corresponding	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
.	NULL

2574	NULL
NOTES	NULL
J	NULL
.	NULL

A	NULL
-	NULL
Noncoding	NULL
Coding	NULL
Coding	NULL
G+AT+C	NULL
U	NULL
B	NULL
G+AT+C	NULL
U	NULL
B	NULL
B	NULL
U	NULL
8	NULL
Qn	NULL
&	NULL
\	NULL
A	NULL
p	NULL
G	NULL
5	NULL
goh	NULL
yt	NULL
s*	NULL
T	NULL
e	NULL
C	NULL
-	NULL
T	NULL
T	NULL
T	NULL
-	NULL
%	NULL
é	NULL
4	NULL
%	NULL
C	NULL
#	NULL
#	NULL
T	NULL
dite	NULL
-	NULL
>	NULL
A	NULL
A	NULL
ya	NULL
G	NULL
Uh	NULL
a=	NULL
A	NULL
poe	NULL
tom	NULL
A	NULL
C	NULL
A	NULL
T	NULL
'	NULL
A	NULL
a	NULL
a	NULL
A	NULL
’	NULL
~~	NULL
o	NULL
.	NULL

a	NULL
C	NULL
a	NULL
.	NULL

C	NULL
*	NULL
T	NULL
‘	NULL
C	NULL
G	NULL
swath	NULL
A	NULL
a	NULL
ge	NULL
®	NULL
C	NULL
pe	NULL
a	NULL
C	NULL
crake	NULL
A	NULL
sooo	NULL
tlle	NULL
T	NULL
C	NULL
C	NULL
T	NULL
A	NULL
T	NULL
a	NULL
T	NULL
T	NULL
C	NULL
3	NULL
s	NULL
C	NULL
t	NULL
A	NULL
G	NULL
tuin	NULL
A	NULL
eme	NULL
|	NULL
A	NULL
wos	NULL
A	NULL
C	NULL
ween	NULL
ume	NULL
T	NULL
G	NULL
C	NULL
T	NULL
G	NULL
C	NULL
T	NULL
G	NULL
C	NULL
T	NULL
3	NULL
amma	NULL
*_*	NULL
1	NULL
-	NULL
20	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
5	NULL
-AGCAGTTTCTGGAAAGTCCCACCTCAGT-3	NULL
'	NULL
3	NULL
'	NULL
-TCGTCAAAGACCTTTCAGGCGTGGAGTCA-S5	NULL
'	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

(	NULL
A	NULL
)	NULL
DNase	NULL
I	NULL
footprint	NULL
of	NULL
the	NULL
coding	NULL
and	NULL
noncoding	NULL
strand	NULL
of	NULL
DEN	NULL
DNA	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
activated	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
nucleotides	NULL
indicated	NULL
by	NULL
the	NULL
vertical	NULL
lines	NULL
correspond	NULL
to	NULL
protected	NULL
bases	NULL
,	NULL
and	NULL
the	NULL
bracketed	NULL
nucleotides	NULL
identify	NULL
the	NULL
NF-xB	NULL
binding	NULL
site	NULL
.	NULL

Lanes	NULL
3	NULL
and	NULL
7	NULL
represent	NULL
unbound	NULL
DNA	NULL
,	NULL
and	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
represent	NULL
bound	NULL
DNA	NULL
.	NULL

The	NULL
DNase	NULL
I	NULL
footprint	NULL
of	NULL
recombinant	NULL
NF-kB	NULL
p50	NULL
protein	NULL
bound	NULL
to	NULL
DEN	NULL
DNA	NULL
labeled	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
is	NULL
shown	NULL
in	NULL
lane	NULL
9	NULL
.	NULL

Lane	NULL
10	NULL
is	NULL
the	NULL
footprint	NULL
of	NULL
unbound	NULL
DNA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Sequence	NULL
of	NULL
protected	NULL
bases	NULL
for	NULL
the	NULL
DEN	NULL
DNA	NULL
coding	NULL
strand	NULL
(	NULL
top	NULL
)	NULL
and	NULL
the	NULL
noncoding	NULL
strand	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

Protected	NULL
bases	NULL
are	NULL
indicated	NULL
by	NULL
a	NULL
bold	NULL
line	NULL
.	NULL

Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
276	NULL
I	NULL
NOTES	NULL
-	NULL
2575	NULL
367	NULL
I	NULL
ACTCARGATAMAGCGAAACTAGCAGCAGTTTGTEGAAAGTICCCACCTCAGTTTCAAGTTCCCCAAAAGACCGGGAAAAACCCCAAGCCTTATT	NULL
GATA	NULL
MLPAL	NULL
NF-kB	NULL
ETS	NULL
ACTCAGATAAAGCGAAACTAGCAGCAGTTTCTGGAAAGTCCCACCTCAGTTTCAAGTTCCCCAAAAGACCGGGAAAAACCCCAAGCCTTATT	NULL
m279	NULL
m287	NULL
mGATA	NULL
m3'MLPAL	NULL
m5'NFkB	NULL
m3'NFKkB	NULL
m323	NULL
m333	NULL
mets	NULL
m352	NULL
m359	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Protein	NULL
binding	NULL
sites	NULL
and	NULL
mutations	NULL
in	NULL
the	NULL
DEN	NULL
region	NULL
.	NULL

Protein	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
GATA	NULL
,	NULL
MLPal	NULL
,	NULL
NF-kB	NULL
,	NULL
and	NULL
Ets	NULL
proteins	NULL
are	NULL
delineated	NULL
by	NULL
boxes	NULL
.	NULL

The	NULL
numbers	NULL
above	NULL
the	NULL
sequence	NULL
correspond	NULL
to	NULL
those	NULL
of	NULL
the	NULL
MCF13	NULL
LTR	NULL
that	NULL
we	NULL
have	NULL
published	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Bases	NULL
within	NULL
DEN	NULL
that	NULL
were	NULL
mutated	NULL
are	NULL
underlined	NULL
.	NULL

tated	NULL
in	NULL
m333	NULL
were	NULL
identified	NULL
as	NULL
part	NULL
of	NULL
the	NULL
enhancer	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
gene	NULL
(	NULL
1	NULL
)	NULL
for	NULL
which	NULL
no	NULL
DNA-binding	NULL
protein	NULL
has	NULL
yet	NULL
been	NULL
identified	NULL
.	NULL

A	NULL
nucleotide	NULL
sequence	NULL
search	NULL
revealed	NULL
no	NULL
transcription	NULL
factor	NULL
site	NULL
that	NULL
corresponds	NULL
to	NULL
the	NULL
bases	NULL
mutated	NULL
in	NULL
m323	NULL
.	NULL

Competition	NULL
gel	NULL
shift	NULL
assays	NULL
confirmed	NULL
the	NULL
presence	NULL
of	NULL
NF-KB	NULL
in	NULL
nuclear	NULL
extract	NULL
from	NULL
activated	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Protein	NULL
binding	NULL
to	NULL
a	NULL
°°P-labeled	NULL
oligonucleotide	NULL
probe	NULL
for	NULL
NF-xB	NULL
was	NULL
effectively	NULL
competed	NULL
by	NULL
the	NULL
cognate	NULL
unlabeled	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
3	NULL
to	NULL
6	NULL
)	NULL
but	NULL
not	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
MLPal	NULL
protein-binding	NULL
site	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
10	NULL
)	NULL
.	NULL

Although	NULL
NF-kB	NULL
is	NULL
ubiquitously	NULL
expressed	NULL
,	NULL
its	NULL
activity	NULL
is	NULL
especially	NULL
critical	NULL
for	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
cytokine-inducible	NULL
gene	NULL
expression	NULL
,	NULL
including	NULL
those	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
,	NULL
6	NULL
,	NULL
12	NULL
)	NULL
.	NULL

When	NULL
T	NULL
cells	NULL
are	NULL
stimulated	NULL
by	NULL
antigen	NULL
presentation	NULL
,	NULL
mitogens	NULL
,	NULL
or	NULL
cytokines	NULL
,	NULL
NF-kB	NULL
is	NULL
released	NULL
from	NULL
its	NULL
inhibitor	NULL
,	NULL
IxB	NULL
in	NULL
the	NULL
cytosol	NULL
,	NULL
and	NULL
is	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
transactivates	NULL
cellular	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
the	NULL
interleukin-2	NULL
and	NULL
interleukin-2	NULL
receptor	NULL
alpha	NULL
chain	NULL
genes	NULL
(	NULL
2-4	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Besides	NULL
its	NULL
activation	NULL
of	NULL
cellular	NULL
genes	NULL
,	NULL
NF-KB	NULL
also	NULL
regulates	NULL
the	NULL
transcription	NULL
of	NULL
viral	NULL
genes	NULL
,	NULL
including	NULL
those	NULL
of	NULL
retroviruses	NULL
(	NULL
7	NULL
,	NULL
8	NULL
,	NULL
22	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
LTR	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
has	NULL
been	NULL
well	NULL
documented	NULL
(	NULL
4	NULL
,	NULL
12	NULL
,	NULL
22	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
it	NULL
has	NULL
been	NULL
observed	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
and/or	NULL
other	NULL
Rel-related	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
LTR	NULL
of	NULL
other	NULL
retroviruses	NULL
,	NULL
such	NULL
as	NULL
the	NULL
bovine	NULL
leukemia	NULL
virus	NULL
(	NULL
8	NULL
)	NULL
and	NULL
the	NULL
avian	NULL
leukosis	NULL
virus	NULL
(	NULL
7	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
induction	NULL
of	NULL
NF-kB	NULL
by	NULL
TABLE	NULL
1	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
DEN	NULL
mutants	NULL
%	NULL
Wild-type	NULL
activity	NULL
``	NULL
Mutant	NULL
clone	NULL
``	NULL
MATA	NULL
.s	NULL
.	NULL

cece	NULL
neenee	NULL
neenee	NULL
rene	NULL
ren	NULL
rene	NULL
renner	NULL
ren	NULL
ene	NULL
nen	NULL
ene	NULL
nen	NULL
nee	NULL
93.1	NULL
+	NULL
1.8	NULL
...	NULL
...	NULL
...	NULL
92.3	NULL
+	NULL
10.8	NULL
*	NULL
The	NULL
mutated	NULL
bases	NULL
in	NULL
DEN	NULL
corresponding	NULL
to	NULL
each	NULL
mutant	NULL
clone	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4.	NULL
b	NULL
CgAT	NULL
activities	NULL
of	NULL
mutant	NULL
clones	NULL
are	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
wild-type	NULL
DEN	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
treated	NULL
with	NULL
TPA	NULL
and	NULL
ionomycin	NULL
.	NULL

Each	NULL
value	NULL
represents	NULL
the	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
of	NULL
at	NULL
least	NULL
two	NULL
independent	NULL
transfec-tions	NULL
performed	NULL
in	NULL
at	NULL
least	NULL
two	NULL
different	NULL
experiments	NULL
.	NULL

The	NULL
range	NULL
of	NULL
CAT	NULL
activity	NULL
was	NULL
0.3	NULL
x	NULL
10°	NULL
to	NULL
6	NULL
x	NULL
10°	NULL
cpm	NULL
after	NULL
correction	NULL
for	NULL
background	NULL
(	NULL
approximately	NULL
3	NULL
%	NULL
10°	NULL
cpm	NULL
)	NULL
.	NULL

More	NULL
than	NULL
one	NULL
plasmid	NULL
preparation	NULL
for	NULL
each	NULL
clone	NULL
was	NULL
tested	NULL
.	NULL

the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
protein	NULL
(	NULL
5	NULL
,	NULL
20	NULL
)	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
this	NULL
human	NULL
retrovirus	NULL
.	NULL

Our	NULL
data	NULL
do	NULL
not	NULL
indicate	NULL
which	NULL
NF-	NULL
«	NULL
xB/Rel	NULL
family	NULL
member	NULL
binds	NULL
the	NULL
MCF13	NULL
LTR	NULL
.	NULL

However	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
predominant	NULL
proteins	NULL
of	NULL
this	NULL
family	NULL
in	NULL
T	NULL
lymphocytes	NULL
and	NULL
the	NULL
thymus	NULL
are	NULL
p50	NULL
,	NULL
c-Rel	NULL
,	NULL
RelA	NULL
,	NULL
and	NULL
ReIB	NULL
(	NULL
4	NULL
,	NULL
9	NULL
,	NULL
10	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
DEN	NULL
region	NULL
is	NULL
important	NULL
for	NULL
MCF	NULL
lymphomagenesis	NULL
,	NULL
it	NULL
will	NULL
be	NULL
intriguing	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
role	NULL
of	NULL
in	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
LTR	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
is	NULL
also	NULL
required	NULL
for	NULL
viral	NULL
pathogenicity	NULL
.	NULL

We	NULL
thank	NULL
Tess	NULL
Chapman	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
and	NULL
Steven	NULL
King	NULL
for	NULL
helpful	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
PHS	NULL
grant	NULL
CA44166	NULL
awarded	NULL
to	NULL
FK.Y	NULL
.	NULL

R.S	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
Rumble	NULL
Fellowship	NULL
from	NULL
Wayne	NULL
State	NULL
University	NULL
,	NULL
and	NULL
S.I	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
postgraduate	NULL
training	NULL
award	NULL
from	NULL
the	NULL
Universiti	NULL
Malaysia	NULL
Sarawak	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Augereau	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
P.	NULL
Chambon	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
mouse	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
:	NULL
effect	NULL
on	NULL
transcription	NULL
in	NULL
vitro	NULL
and	NULL
binding	NULL
of	NULL
proteins	NULL
present	NULL
in	NULL
HeLa	NULL
and	NULL
lymphoid	NULL
B	NULL
cell	NULL
extracts	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

5:1791-1797	NULL
.	NULL

2	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
is	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
53:211-217	NULL
.	NULL

3	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IxB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546	NULL
.	NULL

4	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141-179	NULL
.	NULL

5	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
Y.	NULL
Wano	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

HTLV-I	NULL
tax	NULL
induces	NULL
cellular	NULL
proteins	NULL
that	NULL
activate	NULL
the	NULL
«	NULL
B	NULL
element	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
(	NULL
alpha	NULL
)	NULL
gene	NULL
.	NULL

Science	NULL
241:1652-1655	NULL
.	NULL

6	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
V.	NULL
Azarenko	NULL
,	NULL
Y.	NULL
M.	NULL
Tomita	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1992	NULL
.	NULL

Lymphocyte	NULL
activation	NULL
and	NULL
the	NULL
family	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
complexes	NULL
.	NULL

Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

182	NULL
;	NULL
411-420	NULL
.	NULL

7	NULL
.	NULL

Bowers	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
L.	NULL
A.	NULL
Baglia	NULL
,	NULL
and	NULL
A.	NULL
Ruddell	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
avian	NULL
leukosis	NULL
virus	NULL
long	NULL
terminal	NULL
repeat-enhanced	NULL
transcription	NULL
by	NULL
C/EBP-Rel	NULL
interactions	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:3051-3059	NULL
.	NULL

8	NULL
.	NULL

Brooks	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
J.	NULL
K.	NULL
Nyborg	NULL
,	NULL
and	NULL
G.	NULL
L.	NULL
Cockerell	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
bovine	NULL
leukemia	NULL
virus	NULL
promoter	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:6005-6009	NULL
.	NULL

9	NULL
.	NULL

Carrasco	NULL
,	NULL
D.	NULL
,	NULL
R.-P.	NULL
Ryseck	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1993	NULL
.	NULL

Expression	NULL
of	NULL
relB	NULL
transcripts	NULL
during	NULL
lymphoid	NULL
organ	NULL
development	NULL
:	NULL
specific	NULL
expression	NULL
in	NULL
dendritic	NULL
antigen-presenting	NULL
cells	NULL
.	NULL

Development	NULL
118:1221-1231	NULL
.	NULL

10	NULL
.	NULL

Carrasco	NULL
,	NULL
D.	NULL
,	NULL
F.	NULL
Weih	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1994	NULL
.	NULL

Developmental	NULL
expression	NULL
of	NULL
the	NULL
mouse	NULL
c-ref	NULL
proto-oncogene	NULL
in	NULL
hematopoietic	NULL
organs	NULL
.	NULL

Development	NULL
120	NULL
:	NULL
2991-3004	NULL
.	NULL

11	NULL
.	NULL

Chen	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
F.	NULL
K.	NULL
Yoshimura	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
region	NULL
of	NULL
a	NULL
murine	NULL
leukemia	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
with	NULL
novel	NULL
transcriptional	NULL
regulatory	NULL
activities	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:3308-3316	NULL
.	NULL

12	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
J.-S.	NULL
Chiu	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1993	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
and	NULL
Rel	NULL
:	NULL
participants	NULL
in	NULL
a	NULL
multiform	NULL
transcriptional	NULL
regulatory	NULL
system	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

143	NULL
:	NULL
1-62	NULL
.	NULL

13	NULL
.	NULL

Gunther	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
ETS	NULL
domain	NULL
proteins	NULL
in	NULL
murine	NULL
T	NULL
lymphocytes	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7569-7580	NULL
.	NULL

14	NULL
.	NULL

Gunther	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Nye	NULL
,	NULL
R.	NULL
S.	NULL
Bryner	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1990	NULL
.	NULL

Sequence-specific	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
proto-oncoprotein	NULL
ets-1	NULL
defines	NULL
a	NULL
transcriptional	NULL
activator	NULL
sequence	NULL
within	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
the	NULL
Moloney	NULL
2576	NULL
15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

NOTES	NULL
murine	NULL
sarcoma	NULL
virus	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:667-679	NULL
.	NULL

Ho	NULL
,	NULL
L-C.	NULL
,	NULL
N.	NULL
K.	NULL
Bhat	NULL
,	NULL
L.	NULL
R.	NULL
Gottschalk	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
C.	NULL
B.	NULL
Thomp	NULL
T.	NULL
S.	NULL
Papas	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1990	NULL
.	NULL

Sequence-specific	NULL
binding	NULL
of	NULL
human	NULL
Ets-1	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
alpha	NULL
gene	NULL
enhancer	NULL
.	NULL

Science	NULL
250:814-818	NULL
.	NULL

Ho	NULL
,	NULL
I.-C.	NULL
,	NULL
P.	NULL
Vorhees	NULL
,	NULL
N.	NULL
Marin	NULL
,	NULL
B.	NULL
K.	NULL
Oakley	NULL
,	NULL
S.-F.	NULL
Tsai	NULL
,	NULL
S.	NULL
H.	NULL
Orkin	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
GATA-3	NULL
:	NULL
a	NULL
lincage-restricted	NULL
transcription	NULL
factor	NULL
that	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
alpha	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:1187-1192	NULL
.	NULL

Ko	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
M.	NULL
Yamamoto	NULL
,	NULL
M.	NULL
W.	NULL
Leonard	NULL
,	NULL
K.	NULL
M.	NULL
George	NULL
,	NULL
P.	NULL
Ting	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Engel	NULL
.	NULL

1991	NULL
.	NULL

Murine	NULL
and	NULL
human	NULL
T-lymphocyte	NULL
GATA-3	NULL
factors	NULL
mediate	NULL
transcription	NULL
through	NULL
a	NULL
cis-regulatory	NULL
element	NULL
within	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
delta	NULL
gene	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:2778-2784	NULL
.	NULL

LeClair	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
M.	NULL
A.	NULL
Blanar	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
associates	NULL
with	NULL
the	NULL
NF-IL6	NULL
transcription	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:8145-8149	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58:227-229	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1988	NULL
.	NULL

HTLV-I	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
.	NULL

333:776-778	NULL
.	NULL

Marine	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
A.	NULL
Winoto	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
human	NULL
enhancer-binding	NULL
protein	NULL
Gata3	NULL
binds	NULL
to	NULL
several	NULL
T-cell	NULL
receptor	NULL
regulatory	NULL
elements	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3999-4010	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
326	NULL
:	NULL
711-713	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
N.	NULL
L.	NULL
Edwards	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
and	NULL
G.	NULL
J	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

J.	NULL
ViRoL	NULL
.	NULL

Nabel	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
cooperative	NULL
interaction	NULL
between	NULL
NF-kB	NULL
and	NULL
Sp1	NULL
is	NULL
required	NULL
for	NULL
HIV-1	NULL
enhancer	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3551-3558	NULL
.	NULL

Sayers	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
W.	NULL
Schmidt	NULL
,	NULL
and	NULL
F.	NULL
Eckstein	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
rapid	NULL
generation	NULL
of	NULL
oligonucleotide-directed	NULL
mutations	NULL
at	NULL
high	NULL
frequency	NULL
using	NULL
phosphorothio-ate-modified	NULL
DNA	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16:791-802	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
P.	NULL
Angel	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1993	NULL
.	NULL

Cross-coupling	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
Fos/Jun	NULL
transcription	NULL
factors	NULL
produces	NULL
potentiated	NULL
biological	NULL
function	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3879-3891	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
C.	NULL
Cogswell	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Functional	NULL
and	NULL
physical	NULL
associations	NULL
between	NULL
NF-kB	NULL
and	NULL
C/EBP	NULL
family	NULL
members	NULL
:	NULL
a	NULL
Rel	NULL
domain-bZIP	NULL
interaction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3964-3974	NULL
.	NULL

Tupper	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
H.	NULL
Chen	NULL
,	NULL
E.	NULL
F.	NULL
Hays	NULL
,	NULL
G.	NULL
C.	NULL
Bristol	NULL
,	NULL
and	NULL
F.	NULL
K.	NULL
Yoshimura	NULL
.	NULL

1992	NULL
.	NULL

Contributions	NULL
to	NULL
transcriptional	NULL
activity	NULL
and	NULL
to	NULL
viral	NULL
leukemogenicity	NULL
made	NULL
by	NULL
sequences	NULL
within	NULL
and	NULL
downstream	NULL
of	NULL
the	NULL
MCF13	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancer	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:7080-7088	NULL
.	NULL

Weib	NULL
,	NULL
F.	NULL
,	NULL
D.	NULL
Carrasco	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1994	NULL
.	NULL

Constitutive	NULL
and	NULL
inducible	NULL
Rel/	NULL
NF-	NULL
«	NULL
B	NULL
activities	NULL
in	NULL
mouse	NULL
thymus	NULL
and	NULL
spleen	NULL
.	NULL

Oncogene	NULL
9:3289-3297	NULL
.	NULL

Yoshimura	NULL
,	NULL
F.	NULL
K.	NULL
,	NULL
B.	NULL
Davidson	NULL
,	NULL
and	NULL
K.	NULL
Chaffin	NULL
.	NULL

1985	NULL
.	NULL

Murine	NULL
leukemia	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
sequences	NULL
can	NULL
enhance	NULL
gene	NULL
activity	NULL
in	NULL
a	NULL
cell-type-specific	NULL
manner	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

5:2832-2835	NULL
.	NULL

Yoshimura	NULL
,	NULL
F.	NULL
K.	NULL
,	NULL
and	NULL
K.	NULL
Diem	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
nuclear	NULL
protein	NULL
binding	NULL
to	NULL
a	NULL
site	NULL
in	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
a	NULL
murine	NULL
leukemia	NULL
virus	NULL
:	NULL
comparison	NULL
with	NULL
the	NULL
NFAT	NULL
complex	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:994-1000	NULL
.	NULL

Yoshimura	NULL
,	NULL
F.	NULL
K.	NULL
,	NULL
K.	NULL
Diem	NULL
,	NULL
H.	NULL
Chen	NULL
,	NULL
and	NULL
J.	NULL
Tupper	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
protein-binding	NULL
site	NULL
with	NULL
dyad	NULL
symmetry	NULL
in	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
the	NULL
MCF13	NULL
murine	NULL
leukemia	NULL
virus	NULL
that	NULL
contributes	NULL
to	NULL
transcriptional	NULL
activity	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:2298-2304	NULL
.	NULL

